Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Rocket's Danon plans; Novo leaves Ascendis; Lilly's latest deal

Plus news about Corbus, Syntis, Arrowhead, BioMarin, BioVie, Agomab, Antelope Therapeutics, Connect Biopharma and Genfit. Rocket Pharmaceuticals aligns with FDA on Danon: The commercial-stage biotech said it reached alignment with the ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Tuesday 15 September →